Clinical Trials in Georgia

Showing 4421-4440 of 19,050 trials

PTG-300 in Subjects With Hereditary Hemochromatosis

NCT04202965

This study will be conducted at multiple sites and every patient will get treated with PTG-300. The objective of the study is to assess the effect of PTG-300 in treating adult hereditary hemochromatosis patients.

Hereditary Hemochromatosis

Protagonist Therapeutics, Inc.16 participantsStarted Mar 2020

Fayetteville, Georgia, United States • Bethesda, Maryland, United States • Charlotte, North Carolina, United States +8 more locations

RECRUITINGNA65 miles

Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition

NCT06094478

Most stroke patients are initially evaluated at the closest hospital but some need to be transferred to a hospital that can provide more advanced care. The "Door-In-Door-Out" (DIDO) process at the first hospital can take time making transferred patients no longer able to get the advanced treatments. This study will help hospitals across the US "stand up" new ways to evaluate stroke patients, decide who needs to be transferred, and transfer them quickly for advanced treatment.

Stroke, AcuteIschemic Stroke, AcuteHemorrhagic Stroke

University of Chicago900 participantsStarted Oct 2024

New Haven, Connecticut, United States • Miami, Florida, United States • Atlanta, Georgia, United States +4 more locations

PTG-300 in Subjects With Hereditary Hemochromatosis

Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition

Find Trials by Condition in Georgia

Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation

A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial

Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas

Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears

Registry of Avive® Soft Tissue Membrane Utilization in Selected Applications of Acute Trauma of the Upper Extremity

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Families Left Behind

Trial of Mosunetuzumab (BTCT4465A) as Consolidation Therapy in Participants With Diffuse Large B-Cell Lymphoma Following First-Line Immunochemotherapy and as Monotherapy or in Combination With Polatuzumab Vedotin in Elderly/Unfit Participants With Previously Untreated Diffuse Large B-Cell Lymphoma

A Proof-of-concept Study of the Efficacy and Safety of Nipocalimab in Participants With Active Rheumatoid Arthritis

A Study of Combination of Daratumumab and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants With Previously Untreated Multiple Myeloma

A Study Assessing KB407 for the Treatment of Cystic Fibrosis

Sickle Cell Disease, Hemechip

A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis

INCB050465 in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previously Treated B-Cell Lymphoma (CITADEL-112)

A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors

An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant

[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

STICH3C Cardiac Magnetic Resonance Observational Study